Top Markets
Coin of the day
Avivagen Inc. Avivagen Inc.

Avivagen Inc.

VIV
Rangering i aksjer #40244
Avivagen Inc. is a life sciences enterprise that invents and sells specialized... Avivagen Inc. is a life sciences enterprise that invents and sells specialized products, primarily for animal feed, aimed at bolstering the immune systems of livestock. These solutions are designed to enhance animals' health, leading to improved growth and overall productivity. The company's diverse product lineup features OxC-beta Livestock, a crucial premix for farm animal diets. Beyond agriculture, Avivagen also manufactures health supplements such as Vivamune and Dr. Tobias-branded chews for dogs, along with the Dr. Tobias Beta blend, formulated to support human immunity. Established in 2005 and based in Ottawa, Canada, Avivagen Inc. distributes its offerings across numerous international markets, including the United States, Canada, the Philippines, Taiwan, Thailand, China, Mexico, Brazil, and Malaysia.
Aksjekurs
$0.00368316
Sist synkronisert: 2024-03-04
Markedsverdi
$199.43K
Endring (1 dag)
0.05%
Endring (1 år)
0.00%
Land
CA
Handel Avivagen Inc. (VIV)

Kategori

Pris VIV pris med markedsverdi på B
Avivagen Inc. Avivagen Inc.
VIV
$0.00368316
Markedsverdi av Avivagen Inc.(VIV)
Markedsverdi: $199.43K
Per August 2026 har Avivagen Inc. en markedsverdi på $199.43K. Dette gjør Avivagen Inc. til det 40244th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Avivagen Inc. fra 2007 til 2026
VIV sammenlignet med topp 5 mest populære stocks
Pris på VIV Eiendel B Markedsverdi for B Resultater
Avivagen Inc. Avivagen Inc.
$101,013 $199.43K
$5.470T +2,742,557,322.10%
Avivagen Inc. Avivagen Inc.
$82,499.03 $199.43K
$4.467T +2,239,896,538.59%
Avivagen Inc. Avivagen Inc.
$77,093.65 $199.43K
$4.174T +2,093,137,341.70%
Avivagen Inc. Avivagen Inc.
$68,333.99 $199.43K
$3.700T +1,855,307,404.84%
Avivagen Inc. Avivagen Inc.
$52,714.74 $199.43K
$2.854T +1,431,235,787.47%